Postmarket Problems: FDA Struggles To Achieve Manufacturer Compliance

CDRH's cardiovascular review division has faced resistance from PMA sponsors in complying with post-approval study requirements that involve new patient registries, an official from the division reported May 9 at the North American Society of Pacing and Electrophysiology annual meeting